EC and UK’s FSA confirm validity of CBDepot’s application for trans-CBD as Novel Food substance

news-releasesCBDepot s.r.o.

March 2nd 2022

Teplice, Czech Republic: – The European Commission and UK Food Safety Agency (FSA) have both declared as valid the latest Novel Food application NF 2021/2283 for isolated trans-Cannabidiol (CBD) from pioneering producer and B2B supplier of upmarket cannabinoid solutions, CBDepot. This now increases to four the number of CBDepot Novel Food applications validated by the authorities.

CBDepot’s commitment to Novel Food compliance began in early 2016, shortly after Cannabis Pharma launched the CBDex® brand. CBDepot’s EU application NF 2019/1371, covering synthesized trans-Cannabidiol became the first-ever CBD-specific dossier to reach validation on March 27th, 2020.

Significant market access

In early January 2021, CBDepot filed two Regulated Product applications with the UK FSA to grant access for its two grades of Cannabidiol to the most significant legal CBD food supplement market worldwide.

These were:

Application RP70, for Synthesized Cannabidiol with 4MP®- branded secondary products in the forms of carrier oils, measured dose spray, and chewable tablets
Application RP85, for Isolated Cannabidiol and CBDex®-branded secondary products in the form of carrier oils linked to this dossier

In April 2021, both RP70 and RP85 were declared valid by UK FSA.

CBDepot group’s Chief Sales Officer Boris Baňas commented: “Having four validated applications out of four submitted and appearing on the shortlist of the few validated applications, confirms CBDepot’s position as the leader in the compliant, upmarket cannabinoid sector.”

About CBDepot

CBDepot is an innovative and recognized producer and B2B supplier of upmarket natural and synthesized cannabinoid ingredients to fast-growing markets in the food, cosmetics, pharmaceuticals and health products industries sectors.

CBDepot specializes in bulk supply of cannabinoid-based ingredients for food, cosmetics and pharmaceutical sectors. Its products ensure that content of tetrahydrocannabinol (THC), the main intoxicating element of cannabis, is below detectable levels. Instead, its products emphasize the two other main natural ingredients, cannabidiol (CBD) and cannabigerol (CBG).

Established in 2014, CBDepot has become a leader in helping to establish legal and quality standards for cannabinoid ingredients and the formulation of cannabidiol derivatives. Since foundation it has operated under legal license granted by the government of the Czech Republic.

The company’s initial mission was the supply of “Legal and Quality CBD” at a time when sourcing ethical and quality isolated CBD was a challenge. CBDepot’s scientific knowledge is based on close links with the Czech Academy of Sciences.

The company’s Chief Sales Officer, Boris Baňas, is an ex-board member of the European Industrial Hemp Association (EIHA), where he successfully campaigned for the establishment of new Europe-wide standards.